نوع مقاله : مقاله پژوهشی
نویسندگان
1 استادیار گروه جراحی عروق، گروه جراحی عروق، دانشکده پزشکی، بیمارستان سینا، دانشگاه علوم پزشکی تهران، تهران، ایران
2 رزیدنت جراحی عمومی، دانشکده پزشکی،بیمارستان سینا، دانشگاه علوم پزشکی تهران، تهران، ایران
3 استادیار پزشکی پیشگیری و اجتماعی، مرکز تحقیقات سلامت سالمندان، دانشگاه علوم پزشکی سبزوار، سبزوار، ایران
4 دانشیار گروه جراحی عروق، گروه جراحی عروق، دانشکده پزشکی، بیمارستان سینا، دانشگاه علوم پزشکی تهران، تهران، ایران
چکیده
زمینه و هدف: کاتترهای وریدی یک انتخاب محبوب و در دسترس برای بیماران ESRD هستند اما با شیوع بالای عوارضی ازجمله ترومبوز و عفونت همراهی دارند. هدف این مطالعه تعیین طول عمر، کارکرد و عوارض پرمیکت وریدی فمورال در کاتترهای تعبیهشده در بیمارستان سینا تهران طی سالهای 1402-1401 میباشد.
مواد و روشها: این مطالعه همگروهی آیندهنگر بر روی 100 نفر از بیماران بالای 18 سال که برای تعبیه پرمیکرت فمورال به بیمارستان سینای تهران مراجعه کردند، انجام گردید. بیماران از نظر طول عمر، کارکرد و عوارض زودهنگام و علل failure کاتتر وریدی فمورال، مدت 18- 12 ماه مورد بررسی قرار گرفتند. ابزار جمعآوری اطلاعات، پرسشنامه بود. برای تحلیل دادهها از نرمافزار SPSS22و آزمونهای آماری تی تست و کای اسکوار / Fissure exact test استفاده شد.
یافته ها: شایعترین بیماری همراه در بیماران موردبررسی فشار خون (95 درصد)، بیماری هماتولوژیک (60 درصد) و دیابت (46 درصد) بود. عفونت در 37 درصد افراد جزء شایعترین عوارض بود و پس از آن خونریزی و آسیب عروق مرکزی (5 درصد) در مرتبه دوم قرار گرفتند. طول عمر پرمیکت تعبیهشده 33.65 ± 30.92 هفته بود. سن، جنسیت، فشارخون، دیابت و بیماری هماتولوژیک، در بروز عفونت، تأثیر آماری معنیداری نداشتند (Pvalue>0.05).
نتیجه گیری: شایعترین عارضه زودهنگام تعبیه پرمیکرت فمورال، عفونت بود. نتایج این پژوهش بر لزوم بهکارگیری اقدامات پیشگیرانه برای بروز این عارضه تأکید دارد و باعث پیشگیری از مرگومیر و کاهش هزینه های نظام سلامت میشود.
تازه های تحقیق
https://scholar.google.com/citations?user=zkUA8b8AAAAJ&hl=fa
https://pubmed.ncbi.nlm.nih.gov/?term=Roozbeh+Cheraghali
https://scholar.google.com/citations?user=6UojvGsAAAAJ&hl=en
https://pubmed.ncbi.nlm.nih.gov/?term=Maryam%20Ghasemi
https://scholar.google.com/citations?user=UO6BoIEAAAAJ&hl=en
https://pubmed.ncbi.nlm.nih.gov/?term=parastoo%20amiri&sort=pubdate&page=2
https://scholar.google.com/scholar?hl=en&as_sdt=0,5&q=pezhman+farshidmehr&btnG=
https://pubmed.ncbi.nlm.nih.gov/?term=Pezhman+Farshidmehr
کلیدواژهها
موضوعات
عنوان مقاله [English]
Evaluate the Longevity, Function, and Complications of Femoral Vein Permcath Implanted at Sina Hospital in Tehran During the Years 2022-2023
نویسندگان [English]
- Roozbeh Cheraghali 1
- Maryam Ghasemi 2
- Parastoo Amiri 3
- Pezhman, Farshidmehr 4
1 Assistant Professor of Vascular Surgery, Department of Vascular Surgery, School of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 Resident of General Surgery, School of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
3 3. Assistant Professor of Preventive and Community Medicine, Iranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, Iran
4 Associated Professor of Vascular Surgery, Department of Vascular Surgery, School of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
چکیده [English]
Introduction: Venous catheters are a widely used and accessible option for dialysis patients; however, they are associated with a high prevalence of complications, including thrombosis and infection. This study evaluates the longevity, function, and complications of femoral venous Permcath implanted at Sina Hospital in Tehran from 2022 to 2023.
Materials and Methods: This research is a cohort study of a prospective longitudinal design conducted on 100 patients over 18 years old referred to Sina Hospital for femoral vein Permcath implantation. Patients were assessed for longevity, function, early complications, and causes of the femoral venous catheter failure for 12 to 18 months. Statistical analysis was performed using t-tests for quantitative data and Chi-square tests for qualitative data, utilizing SPSS-22. A statistical significance level of P ≤ 0.05 was.
Results: The results indicated that the most common comorbidities among the studied patients were hypertension (95%), hematological diseases (60%), and diabetes (46%). Infection was the most prevalent complication, occurring in 37% of individuals, followed by bleeding and damage to central vessels (5%). The average longevity of the implanted Permcath was 33.65 ± 30.92 weeks. Factors such as age, gender, blood pressure, diabetes, and hematological diseases did not significantly impact the occurrence of infections
Conclusion: The most frequent early complication associated with femoral venous Permcath implantation was infection. The findings of this study emphasize the necessity of implementing preventive measures to reduce this complication, because it can help prevent mortality and reduce healthcare costs.
کلیدواژهها [English]
- Femoral Vein
- Permcath
- Hemodialysis
- Complications
- Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PloS one. 2016;11(7):e0158765. DOI: 10.1371/journal.pone.0158765
- Russa DL, Pellegrino D, Montesanto A, Gigliotti P, Perri A, Russa AL, et al. Oxidative balance and inflammation in hemodialysis patients: biomarkers of cardiovascular risk? Oxidative medicine and cellular longevity. 2019;2019(1):8567275. DOI: 10.1155/2019/8567275
- Navarro-García JA, Rodríguez-Sánchez E, Aceves-Ripoll J, Abarca-Zabalía J, Susmozas-Sánchez A, González Lafuente L, et al. Oxidative status before and after renal replacement therapy: differences between conventional high flux hemodialysis and on-line hemodiafiltration. Nutrients. 2019;11(11):2809. doi: 10.3390/nu11112809
- Asadi F, Moghaddasi H, Rabiei R, Malekzadeh S. Study on the status of information system for dialysis patients in the Country. Hakim Health Sys Res. 2017;20(2):93-8 [In Persian]
- Sethi J, Gaur M, Rathi M, Kohli HS. Tunneled femoral vein catheterization for long-term hemodialysis–experience from a tertiary care center. Indian Journal of Nephrology. 2022;32(4):371-4. doi: 10.4103/ijn.ijn_224_21
- Chulay M, Suzanne M, Chulay M, Suzanne M. AACN Essentials of Critical Care Nursing Pocket Handbook (80): STIKES PERINTIS PADANG; 2020.
- Dionigi R, Guaglio R, Bonera A, Cerri M, Rondanelli R, Campani M. Clinical-pharmacological aspects, application and effectiveness of total parenteral nutrition in surgical patients. International Journal of Clinical Pharmacology and Biopharmacy. 1979;17(3):107-18.
- Bhola C, Dinwiddie LC. Hemodialysis catheter care: Current recommendations for nursing practice in north america. Nephrology nursing journal. 2010;37(5):5.
- Kher V. Tunneled central venous catheters for dialysis–A necessary evil? Indian Journal of Nephrology. 2011;21(4):221-2. doi: 10.4103/0971-4065.85480
- Fadel FI, Mooty HNA, Bazaraa HM, Sabry SM. Central venous catheters as a vascular access modality for pediatric hemodialysis. International Urology and Nephrology. 2008;40:489-96. doi: 10.1007/s11255-007-9259-x.
- Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL. Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrology Dialysis Transplantation. 2006;21(3):721-8. doi: 10.1093/ndt/gfi281.
- Shahidi S, Soheilipour M. Comparison of vascular access use in hemodialysis patients in Isfahan in 2003 and 2013. Indian journal of nephrology. 2015;25(1):16-20. doi: 10.4103/0971-4065.134656.
- Sullivan R, Samuel V, Le C, Khan M, Alexandraki I, Cuhaci B, et al. Hemodialysis vascular catheter-related bacteremia. The American journal of the medical sciences. 2007;334(6):458-65. doi: 10.1097/MAJ.0b013e318068b24c.
- Akoh JA. Vascular access infections: epidemiology, diagnosis, and management. Current infectious disease reports. 2011;13(4):324-32. doi: 10.1007/s11908-011-0192-x.
- Taylor RW, Palagiri AV. Central venous catheterization. Critical Care Medicine. 2007;35(5):1390-6. doi: 10.1097/01.CCM.0000260241.80346.1B.
- Junker J, Totty W, Stanley R, McClennan B. Computed-tomographic confirmation of femoral vein distension with the Valsalva maneuver. Radiology. 1983;147(1):275-. doi: 10.1148/radiology.147.1.6828748.
- LC G. Short-term femoral vein catheterization. Am J Surg. 1979;138:875-8.
- Kirkpatrick WG, Culpepper RM, Sirmon MD. Frequency of complications with prolonged femoral vein catheterization for hemodialysis access. Nephron. 1996;73(1):58-61. doi: 10.1159/000188999.
- Napalkov P, Felici DM, Chu LK, Jacobs JR, Begelman SM. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis. BMC cardiovascular disorders. 2013;13:1-10. doi: 10.1186/1471-2261-13-86.
- Adib-Hajbagheri M, Molavizadeh N, Alavi NM, Abadi MHM. Factors associated with complications of vascular access site in hemodialysis patients in Isfahan Aliasghar hospital. Iranian journal of nursing and midwifery research. 2014;19(2):208-14.
- O’Dwyer H, Fotheringham T, O’Kelly P, Doyle S, Haslam P, McGrath F, et al. A prospective comparison of two types of tunneled hemodialysis catheters: the Ash Split versus the PermCath. Cardiovascular and interventional radiology. 2005;28:23-9. doi: 10.1007/s00270-003-0230-7
- Parienti J-J, Mongardon N, Mégarbane B, Mira J-P, Kalfon P, Gros A, et al. Intravascular complications of central venous catheterization by insertion site. New England Journal of Medicine. 2015;373(13):1220-9. DOI: 10.1056/NEJMoa1500964
- Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Critical care medicine. 2012;40(8):2479-85. doi: 10.1097/CCM.0b013e318255d9bc.
- Budruddin M, Mohsin N, Amitabh J, Ehab M, Pramod K, Abbas P, et al. Femoral vein tunneled catheters as a last resort to vascular access: report of five cases and review of literature. Renal Failure. 2009;31(4):320-2. doi: 10.1080/08860220902780077.
- Stenzel JP, Green TP, Fuhrman BP, Carlson PE Marchessault RP. Percutaneous femoral venous catheterizations: a prospective study of complications. The Journal of pediatrics. 1989;114(3):411-5. doi: 10.1016/s0022-3476(89)80559-1.
- Afshar M, Savari F, Adib-Hajbagheri M, Gilasi HR, Soleimani A, Baseri AM, et al. Permanent hemodialysis catheter complications in patients referred to Kashan Akhavan dialysis center from June 2013 to December 2013. Feyz Medical Sciences Journal. 2015;19(2):162-8.[In Persian]
- Rupp ME, Karnatak R. Intravascular catheter–related bloodstream infections. Infectious Disease Clinics. 2018;32(4):765-87. doi: 10.1016/j.idc.2018.06.002.
Lee T, Barker J, Allon M. Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes. American journal of kidney diseases. 2005;46(3):501-8. doi:
)